证券研究报告 港股公司|公司点评|吉利汽车（00175） 8 月销量同环比高增，新品周期驱动销 量向上 请务必阅读报告末页的重要声明 glzqdatemark1 2024年09月04日 证券研究报告 |报告要点 2024 年 9 月 1 日，吉利汽车发布 2024 年 8 月产销快报，公司 8 月实现汽车销量 18.1 万辆， 同比+21.5%，环比+20.2%。2024 年 1-8 月汽车累计销量 128.8 万辆，同比+34.0%。8 月公司 新品密集上市，叠加以旧换新政策补贴加码，下半年公司销量有望维持高速增长态势。 |分析师及联系人 高登 陈斯竹 唐嘉俊 SAC：S0590523110004 SAC：S0590523100009 SAC：S0590524080004 请务必阅读报告末页的重要声明 1 / 5 港股公司|公司点评 glzqdatemark2 2024年09月04日 吉利汽车(00175) 8 月销量同环比高增，新品周期驱动销量向上 | --- | --- | --- | |--------------------------|-------|---------------------| ...

Investment Rating - The report maintains a "Buy" rating for the company with a target price adjusted to HKD 12.0, down from HKD 14.3 [5][3]. Core Insights - The company's total revenue for the first half of 2024 decreased by 23% year-on-year, with payment business GPV and revenue declining by 18% and 27% respectively. However, the increase in the proportion of merchant solutions revenue has led to an improvement in overall gross margin [2][3]. - The report anticipates that payment revenue will stabilize in the second half of 2024, projecting adjusted net profits of RMB 250 million and RMB 320 million for 2024 and 2025 respectively [3][2]. Financial Performance Summary - Total revenue for the first half of 2024 was RMB 1.58 billion, with a year-on-year decline of 23%. The one-stop payment service revenue fell by 27% to RMB 1.35 billion, accounting for 85% of total revenue. Merchant solutions revenue increased by 21% to RMB 200 million, raising its share to 13% [2][3]. - Gross profit decreased by 18% to RMB 300 million, with merchant solutions contributing 61% and one-stop payment contributing 31% to gross profit. The overall gross margin improved to 19% due to the higher margin of merchant solutions [2][3]. - The company reported a net profit of RMB 31.6 million, a decline of 5% year-on-year, with adjusted EBITDA falling by 44% to RMB 160 million, primarily due to the drop in payment revenue and adjustments in non-recurring income [2][3]. Business Segment Analysis - Payment business GPV for the first half of 2024 was RMB 1.2 trillion, down 18% year-on-year. The overall payment fee rate was 12.3 bps, compared to 14.1 bps in the first half of 2023 [2][3]. - The number of active merchants in the merchant solutions segment reached approximately 1.6 million, a year-on-year increase of 6%, indicating improved penetration into payment merchants [2][3]. - The e-commerce service segment reported a revenue decline of 52% to RMB 29 million, but the net loss narrowed to RMB 15.6 million, reflecting an optimization in the business model [2][3]. Future Outlook - The report expects macroeconomic consumption to remain weak in July and August, but anticipates a slowdown in the year-on-year decline of payment business GPV to 8% in the second half of 2024, with payment revenue expected to stabilize [3][2]. - The company has announced a USD 10 million share buyback plan to enhance shareholder returns, which may provide some support for the stock price [3][2].

证券研究报告 医药生物 证券分析师 刘闯 S1350524030002 liuchuang@huayuanstock.com 市场表现： 康方生物 恒生指数 -19% -6% 8% 21% 34% 47% 23-0823-1023-1123-1224-0124-0224-0324-0424-0524-0624-0724-08 相关研究 1.《康方生物（9926.HK）：打造新 一代 I/O 创新药旗舰，强势出海未来 可期》，2024.07.29 | --- | --- | |-----------------------|----------------------| | 股价数据： 2024 | 年 9 月 3 日 | | 收盘价（港元） | 49.05 | | 年内最高/最低（港元） | 60.00/26.45 | | 总市值（亿港元） | 424.70 | 公司点评 2024 年 9 月 4 日 康方生物 (9926.HK) 买入（维持） ——业绩符合预期，产品销售持续高增，重磅临床加速推进 投资要点： ➢ 公司事件：康方生物发布 2024 年中期业绩公告，产品收入为 9.4 亿元，同比+24%(去年同 ...

浦银国际研究 财务模型更新 | 互联网行业 浦银国际 财务模型更新 网龙 （777.HK） 网龙（777.HK）：游戏保持相对稳定， 关注新游表现 利润率持续改善：公司 1H24 收入人民币 33.0 亿元，同比下降 10.3%； 其中，游戏及应用服务收入为 21.2 亿元，同比小幅下降 0.8%，主要 是海外游戏收入下滑；Mynd.ai 收入同比下降 23.5%至 11.8 亿元，主 要由于硬件需求回归常态化；毛利率同比改善 4.5pp 至 66.6%，主要 受益于高毛利的游戏收入占比提升；调整后净利润为 5.6 亿元，调整 后净利率为 16.9%。此外，公司宣布派发中期股息每股 0.4 港元。 游戏收入维持相对稳定，关注新游表现：1H24 公司游戏业务维持相 对稳定，收入同比下降 3%至 18.6 亿元；其中，国内游戏收入同比下 降 1.3%，端游保持增长，手游有所下滑；海外游戏收入同比下降 12.9%， 主要是《魔域》端游海外版受外挂影响及《征服》端游海外版受埃及 临时限电影响。这些问题正逐步改善，下半年海外收入有望恢复。国 内端游核心产品《简体魔域》保持良好用户粘性，MAU、DAU 等指标 均实现增长 ...

Investment Rating - The report maintains a "Buy" rating for IGG (799.HK) with a target price of HKD 4.0, representing a potential upside of 21% from the current price of HKD 3.3 [2][4]. Core Insights - IGG's strong performance in both gaming and app businesses is identified as a new growth driver, with a 9% year-on-year revenue increase to HKD 2.7 billion in 1H24 [2]. - The gross margin improved by 6.5 percentage points to 78.8%, primarily due to the increased revenue share from the app business [2]. - Adjusted net profit for 1H24 was HKD 350 million, with an adjusted net profit margin of 12.7% [2]. Revenue Breakdown - Gaming revenue reached HKD 2.3 billion in 1H24, showing a slight increase of 1% year-on-year [2]. - The core product, "King of Kingdoms," experienced a 19% decline in revenue to HKD 1.3 billion, while new games "Doomsday: Last Survivors" and "Viking Rise" generated revenues of HKD 500 million and HKD 300 million, respectively, marking year-on-year growth of 97% and 151% [2]. - The new games accounted for 34% of total gaming revenue, effectively offsetting the decline from older titles [2]. App Business Performance - The app business generated HKD 400 million in revenue during 1H24, reflecting a significant year-on-year growth of 116% and increasing its revenue share to 15% [2]. - Following a business transformation earlier in the year, the app segment focused on content service-oriented applications, leading to a recovery in revenue and user engagement [2]. - Monthly revenue from the app business reached HKD 120 million in July, with expectations for continued high performance in the second half of the year [2]. Financial Projections - The report projects revenues of HKD 5.8 billion and HKD 6.4 billion for FY24E and FY25E, respectively, with adjusted net profits expected to be HKD 650 million and HKD 850 million [2][4].

Investment Rating - The report maintains a "Buy" rating for China TravelSky Technology (00696 HK) with a target price of HKD 14 52 per share based on a 20x PE valuation for 2024 [4][11] Core Views - The company reported strong revenue and profit growth in H1 2024 with revenue reaching RMB 4 042 billion (YoY +22 2%) and net profit attributable to shareholders of RMB 1 367 billion (YoY +13 9%) [2][6] - Domestic air travel recovery remains robust with domestic passenger volume in H1 2024 exceeding 2019 levels by 12 1% while international passenger volume recovered to 76 0% of 2019 levels [2][6] - The AIT (Airline Information Technology) business saw revenue growth of 19 8% YoY to RMB 2 265 billion in H1 2024 driven by strong domestic recovery [2][6] - Settlement and clearing business revenue surged 50 0% YoY to RMB 278 million in H1 2024 due to the recovery of international business volume [2][6] - System integration services revenue increased significantly by 111 9% YoY to RMB 680 million in H1 2024 driven by increased project completions [2][6] - Data network services revenue grew steadily by 7 3% YoY to RMB 216 million in H1 2024 supported by increased distribution information service volume [2][6] Financial Forecasts - Revenue is expected to grow by 22 4% in 2024 and 9 0% in 2025 with net profit attributable to shareholders forecasted at RMB 1 932 billion and RMB 2 297 billion respectively [2][11] - The company's gross margin is expected to improve steadily reaching 53 0% in 2024 and 54 1% in 2025 [11][12] - EPS is projected to be RMB 0 66 in 2024 and RMB 0 79 in 2025 [11][12] Business Performance - The company's AIT business continues to recover with domestic air travel showing strong growth while international travel is gradually recovering [2][6] - The settlement and clearing business is benefiting from the recovery of international air travel and the expansion of system and product services [6][8] - System integration services are experiencing significant growth due to increased project completions and the company's involvement in smart airport construction [6][8] - Data network services are maintaining steady growth with the company expanding its overseas market presence and enhancing its distribution capabilities [6][9] Industry Outlook - The domestic air travel market is expected to continue its natural growth while the international market is projected to further recover in H2 2024 [7] - The company is well-positioned to benefit from the ongoing recovery in the aviation and tourism industry as a key player in civil aviation information technology [11]

Investment Rating - Maintains an "Outperform" rating with a target price adjusted to HKD 6.94 [5][14] Core Views - The company achieved sales of CNY 128.6 billion in 1H24, representing a 4.7% year-over-year (y-y) growth [3][9] - The pharmaceutical manufacturing, distribution, and retail segments contributed 16.5%, 79.6%, and 3.8% to total revenue, respectively [3][9] - Gross profit margin (GPM) improved to 16.3% (+0.2 ppts y-y), driven by higher margins in the pharmaceutical manufacturing segment [3][9] - Net profit reached CNY 5.5 billion (+10.2% y-y), while attributable net profit was CNY 2.6 billion (-2.9% y-y) [3][9] - The company has over 350 projects under research, including approximately 100 new drug projects [3][9] Business Segment Analysis Pharmaceutical Manufacturing - Sales reached CNY 23.8 billion (+5.8% y-y) in 1H24 [3][10] - Traditional Chinese medicine (TCM) sales grew by 12.0% y-y, contributing 50.3% of the segment's revenue [3][10] - The segment's GPM improved to 60.1% (+1.2 ppts y-y) due to product mix changes and process efficiency enhancements [3][10] - The company produced 792 drugs, with 430 included in the National Reimbursement Drug List and 203 in the basic drug list [3][10] Distribution - Sales were CNY 105.9 billion (+4.9% y-y), with medical device distribution contributing CNY 16.7 billion (+3.1% y-y) [3][11] - The segment's GPM slightly declined to 5.9% (-0.2 ppts y-y) [3][11] - The distribution network covers 28 provinces, serving approximately 210,000 clients, including over 10,000 second- and third-tier hospitals [3][11] - The company operates more than 220 logistics centers with nationwide temperature-controlled storage and distribution capabilities [3][11] Retail - Sales grew by 9.3% y-y to CNY 4.9 billion, driven by the high-value drug direct-to-patient (DTP) business, which grew by 19% y-y [3][12] - The segment's GPM decreased to 6.5% (-1.4 ppts y-y) due to the increased proportion of lower-margin DTP business [3][12] - The company operates 760 self-owned retail pharmacies, including 275 DTP pharmacies (162 dual-channel pharmacies) [3][12] Financial Forecasts - Revenue forecasts for 2024/2025/2026 were slightly revised to CNY 263.6 billion, CNY 291.1 billion, and CNY 320.7 billion, respectively [5][13] - Attributable net profit forecasts for 2024/2025/2026 were adjusted to CNY 4.1 billion, CNY 4.5 billion, and CNY 5.0 billion, respectively [5][13] - The adjustments reflect challenges in the pharmaceutical distribution industry and the impact of equity restructuring on attributable net profit [5][13] Valuation - The target price was revised to HKD 6.94, based on a 9.5X PE for 2024, down from HKD 8.12 (previously based on 11X PER) [5][14] - The valuation reflects uncertainties in the distribution industry, including extended reimbursement cycles for medical insurance funds [5][14]

Investment Rating - Maintain "Buy" rating with a target price of HKD 22 [3] Core Views - The company's 1H24 revenue reached RMB 2.22 billion, a YoY increase of 26.7%, with gross margin improving by 8.2pp to 67.4% due to higher self-developed game revenue contribution [2] - Adjusted net profit was RMB 240 million, with an adjusted net margin of 10.7%, and adjusted EBITDA grew by 72.7% YoY to RMB 320 million [2] - Game business revenue increased by 29.3% YoY to RMB 1.49 billion, driven by strong performance of new games such as "Let's Go Muffin" and "Sword of Linlang" [2] - TapTap platform revenue grew by 32.6% YoY to RMB 1.30 billion, with monthly active users (MAU) in China reaching 43.24 million, a YoY increase of 27.3% [2] - The company expects strong growth in game revenue in 2H24 due to the successful launch of new games and the upcoming release of "Let's Go Muffin" in South Korea and Japan [2] Financial Projections - Revenue for 2024E/2025E is projected to be RMB 5.0 billion/RMB 5.3 billion, with adjusted net profit of RMB 570 million/RMB 650 million [3] - The target price of HKD 22 implies a 2024E/2025E P/E of 17.0x/14.7x [3] Game Performance - "Let's Go Muffin" became the top revenue contributor in 1H24 after its launch in Hong Kong, Macau, Taiwan, and mainland China, with plans for expansion into South Korea and Japan [2] - "Heartbeat Town" achieved over 25 million downloads in its first month and is expected to become a product with millions of daily active users (DAU) [2] TapTap Platform - TapTap's user base rebounded, with MAU in China growing by 27.3% YoY and 14.8% QoQ, driven by increased marketing and the launch of popular games [2] - The company has limited ad load rates to improve user experience, which may slightly impact short-term ad revenue growth, but double-digit growth is still expected in 2H24 [2]

浦银国际研究 浦银国际 公司研究 中国飞鹤 （6186.HK） 公司研究 | 消费行业 中国飞鹤（6186.HK）：产品结构高端化 趋势 2H24 有望持续，重申加大派息力度 尽管行业竞争环境依然不容乐观，但经过两年的渠道改革，飞鹤基本 面已大幅改善：渠道库存回到健康水平，终端价盘大幅回升，超高端 新品卓睿销量涨势喜人，整体品牌力与市场份额稳步提升，毛利率同 比大幅扩张。我们预测公司基本面同比改善的趋势将在 2H24 持续。 结合公司依然较低的估值水平以及管理层承诺持续加大的派息力度， 我们认为飞鹤当前股价依然有较高的性价比和吸引力。上调 2024-2026 盈利预测，上调目标价至 5.21 港元，维持"买入"评级。 收入增速好于行业，管理层对 2H24 预期乐观：飞鹤 1H24 的婴配粉 收入同比增长 5%（线下 3%，线下 9%），一定程度上归功于公司加大 了渠道补货力度。管理层表示 1H24 飞鹤终端销售同比小幅正增长（线 下小幅下跌，线上大幅增长），依然好于行业整体表现。我们预计公 司当前渠道库存为一个半月（相较年初半个月），依然处于较为健康 的水平。管理层预计 2H24 收入将加速增长，2024 全 ...

Investment Rating - The report upgrades the investment rating of the company from Hold to Buy, with a target price set at HKD 4.91, reflecting a 10x P/E ratio for 2024 [2][3][4]. Core Insights - The company achieved a net profit growth of 18.9% year-on-year in the first half of 2024, supported by effective cost control and a strong performance in property management services [2][6]. - The management maintains a net profit growth target of over 20% for 2024, driven by the integration of acquired companies and a lower base in the second half of the year [2][3]. - The company's independence has significantly improved, with the proportion of third-party managed saleable area increasing from 33% in 2022 to 50.5% in 2024 [3][4]. Financial Performance - For the first half of 2024, the company reported a revenue increase of 10.2% to RMB 1.5 billion, with property management (PM) revenue growing by 34.6% to RMB 1 billion [2][6]. - The gross profit margin (GPM) for basic PM improved by 1.3 percentage points to 24.6%, while the GPM for community value-added services (VAS) increased by 3.6 percentage points to 42.3% [2][6]. - The company expects to manage an additional 8 million square meters of building area from the acquisition of RUNWU JIAYE, contributing approximately 27% to the annual total [2][3]. Revenue and Profit Forecast - Revenue is projected to grow from RMB 2.7 billion in 2023 to RMB 3.1 billion in 2024, with a compound annual growth rate (CAGR) of 14.4% [5][9]. - Net profit is expected to rise from RMB 337.3 million in 2023 to RMB 399.6 million in 2024, reflecting an 18.5% increase [5][9]. - The earnings per share (EPS) is forecasted to increase from RMB 0.37 in 2023 to RMB 0.44 in 2024 [5][9]. Valuation Metrics - The company is currently trading at a P/E ratio of 5.3x for 2024, which is below the industry average, indicating potential undervaluation [5][12]. - The price-to-book (P/B) ratio is projected to decline from 1.4 in 2023 to 1.2 in 2024, suggesting a more attractive valuation [5][12]. - The dividend yield is expected to increase from 6.6% in 2023 to 7.5% in 2024, enhancing the attractiveness for income-focused investors [5][12].